TRLS — Trellus Health Cashflow Statement
0.000.00%
Last trade - 00:00- £1.29m
- -£1.91m
- $0.11m
- 13
- 29
- 60
- 22
Annual cashflow statement for Trellus Health, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.762 | -5.9 | -8.81 | -6.8 | -8.03 |
| Depreciation | |||||
| Non-Cash Items | — | 0.139 | 0.185 | 0.265 | 0.013 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.111 | 0.959 | -0.531 | 0.548 | -0.172 |
| Change in Accounts Receivable | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.65 | -4.77 | -8.62 | -5.27 | -7.32 |
| Capital Expenditures | -0.674 | -3.72 | -2.91 | -2.35 | -0.54 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Cash from Investing Activities | -0.674 | -3.72 | -2.91 | -2.35 | -0.54 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 5.01 | 38.5 | 0 | 0 | 0 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.68 | 28.3 | -12.9 | -6.92 | -7.82 |